Gentex Pharma, LLC v. Glycobiosciences, Inc.

CourtDistrict Court, S.D. Mississippi
DecidedSeptember 30, 2020
Docket3:19-cv-00645
StatusUnknown

This text of Gentex Pharma, LLC v. Glycobiosciences, Inc. (Gentex Pharma, LLC v. Glycobiosciences, Inc.) is published on Counsel Stack Legal Research, covering District Court, S.D. Mississippi primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Gentex Pharma, LLC v. Glycobiosciences, Inc., (S.D. Miss. 2020).

Opinion

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF MISSISSIPPI NORTHERN DIVISION GENTEX PHARMA, LLC PLAINTIFF Vs. CIVIL ACTION NO. 3:19-cv-645-DCB-RPM GLYCOBIOSCIENCES, INC., KEVIN DRIZEN, JOHN DOES 1-5 DEFENDANTS

SHOW CAUSE ORDER and ORDER DENYING DRIZEN’S MOTION TO DISMISS This matter is before the Court on Defendants Kevin Drizen (“Drizen”)’s and Glycobiosciences, Inc. (“Glyco”)’s Motion to Dismiss, or in the Alternative, Stay Pending Arbitration. [ECF No. 13]. Having read the motion, response thereto, memoranda, applicable statutory and case law, the Court finds as follows: Background Plaintiff has filed suit in this Court against Kevin Drizen (“Drizen”) and Glycobioscience, Inc (“Glyco”) alleging (1) breach of contract, (2)breach of the covenant of good faith and fair

dealing, (3)tortious interference with a business relationship, and (4) fraud, and requests specific performance, and injunctive relief. [ECF No. 1]. Defendants Glyco and Drizen have moved to dismiss based on (1) mootness, (2) lack of personal jurisdiction over Drizen, and (3) failure to state a claim as to Drizen. In the alternative, Defendants move to stay pending arbitration. Gentex has responded to the Defendants’ Motion claiming that Glyco has waived arbitration by filing a subsequent lawsuit in Canada. On August 21, 2020, the Court asked Gentex to Show Cause as to how it has been prejudiced by the Canadian lawsuit. [ECF No. 16].

In Canada, Glyco filed a lawsuit in the Superior Justice Court of Ontario (“Ontario Action”) against Gentex alleging (1) breach of contract, (2)unlawful interference in contractual relations, and (3) negligent and fraudulent misrepresentation. Glyco is asking for special damages and punitive damages. [ECF No. 15, Exhibit D]. Gentex has answered the Ontario Action with a Motion to Dismiss pursuant to an arbitration agreement between Gentex and Glyco. [ECF No. 13, Exhibit F]. The Ontario Action is currently suspended due to the COVID-19 pandemic. [ECF No. 20 at p. 8].

Discussion Mootness

Glyco moves to dismiss this action claiming it is moot. “If a dispute has been settled or resolved, or if it has evanesced because of changed circumstances, including the passage of time, it is considered moot.” In re S.L.E., Inc., 674 F.2d 359, 364 (5th Cir.1982). Defendants assert that the current litigation is moot in light of a 2020 agreement (“2020 Agreement”) between the Parties. The 2020 Agreement does not contain release language nor does it mention the current litigation. “A case is not moot so long as any claim for relief remains viable, whether that claim was the primary or secondary relief originally sought.” Matter of Commonwealth Oil Ref. Co., Inc., 805 F.2d 1175, 1181 (5th Cir. 1986)(internal citation omitted). The 2020 Agreement does not moot the current controversy.

Arbitration The Federal Arbitration Act (“FAA”), 9 U.S.C. 1 et seq., governs the arbitration clause in the 2018 Agreement between Gentex and Glyco. “The FAA provides for district courts to stay legal proceedings on issues referable to arbitration, 9 U.S.C. 3, and empowers the courts to compel arbitration of arbitrable issues 9

U.S.C. 4.” Century Satellite, Inc. v. Echostar Satellite, L.L.C., 395 F. Supp. 2d 487, 490 (S.D. Tex. 2005) (quoting Hartford Lloyd’s Ins. Co. v. Teachworth, 898 F. 2d 1058, 1061 (5th Cir. 1990)). If there is a valid arbitration agreement, the “parties must proceed to arbitration on those claims without a judicial determination on the merits thereof.” Century Satellite, Inc. v. Echostar Satellite, L.L.C., 395 F.Supp.2d 487, 490 (S.D. Tex. 2005). Here, the issue is whether the arbitration agreement between Gentex and Glyco has been waived. “Because of the strong federal policy favoring arbitration, the party opposing arbitration has the burden of establishing any alleged defenses to the enforcement of the arbitration provision.” Byars v. Asbury Mgmt. Servs., LLC, No.

3:19-CV-660-DCB-JCG, 2020 WL 127989, at *2 (S.D. Miss. Jan. 10, 2020). Gentex asserts that Glyco has waived the right to arbitrate by filing a subsequent lawsuit, the Ontario Action. [ECF No. 16].

“The right to arbitrate a dispute, like all contractual rights, is subject to waiver.” Nicholas v. KBR, Inc., 565 F.3d 904, 907 (5th Cir. 2009). However, a waiver of arbitration is disfavored. Id. Merely invoking the judicial process does not result in a waiver. To determine whether there was a waiver, courts must determine whether the party seeking arbitration substantially invoked the judicial process to the detriment or prejudice of the other party. Id. Prejudice refers to delay, expense, or damage to a party’s legal position. Forby v. One Techs., L.P., 909 F.3d 780, 785 (5th Cir. 2018).

Glyco substantially invoked the judicial process when it filed suit against Gentex in the Ontario Action. However, the Court is not persuaded that Gentex suffered prejudice. Gentex argues (1) delay and (2) added expense associated with the Ontario Action has caused prejudice. [ECF No. 21]. Delay in the Ontario Action is due in part to the current

COVID-19 global pandemic, “all proceedings in the Superior Court of Justice of Ontario, Canada, were suspended due to the COVID-19 global pandemic.” [ECF No. 20 at p.8]. The Parties elected in writing not to proceed with the hearing by videoconference. [ECF. No.20, Exhibit 6]. Mere delay is not a basis for prejudice, delay must cause loss of evidence, increased difficulties in discovery, or greater opportunities for fraud and collusion. See Lacy v. Sitel Corp., 227 F.3d 290, 293 (5th Cir. 2000); Ingram v. Chatawa Mgmt. Co., Inc., No. 5:18-CV-40-DCB-MTP, 2018 WL 4517467, at *1 (S.D. Miss. Sept. 20, 2018).

The Fifth Circuit has upheld an arbitration clause even though the defendant participated in discovery and waited eight months after the commencement of the lawsuit to invoke its right to arbitration. Tenneco Resins, Inc. v. Davy Int’s, AG, 770 F 2d 416, 421 (5th Cir. 1985). The Fifth Circuit noted that “when only a minimal amount of discovery has been conducted . . . the court should not ordinarily infer waiver based upon prejudice.” Id. at 421. Similar to Tenneco, the Parties have engaged in minimal discovery consisting of a request to inspect documents and a demand

for particulars. [ECF No. 20]. Gentex has not been prejudiced by the delay in the Ontario Action. The purpose of arbitration is to avoid the expense of litigation. Nicholas, 565 F. 3d at 907. The time and expense Gentex has spent thus far in the Ontario Action is time and expense spent dealing with elementary matters that occur after a complaint is filed: dealing with motions to dismiss and answers to the complaint. The Defendants have incurred similar expenses in this litigation. Consequently, this Court concludes that Gentex has not shown prejudice.

On September 4, 2018, the Parties (Gentex and Glyco) formed an agreement (“the 2018 Agreement”) that includes the following arbitration clause: The Parties hereby voluntarily release one another regarding all issues raised in, or that could have been raised in, the Canadian action and/or the Arbitration.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Alpine View Co Ltd v. Atlas Copco AB
205 F.3d 208 (Fifth Circuit, 2000)
Luv N' Care, Ltd. v. Insta-Mix, Inc.
438 F.3d 465 (Fifth Circuit, 2006)
Seiferth v. Helicopteros Atuneros, Inc.
472 F.3d 266 (Fifth Circuit, 2006)
Nicholas v. KBR, INC.
565 F.3d 904 (Fifth Circuit, 2009)
Calder v. Jones
465 U.S. 783 (Supreme Court, 1984)
Christopher v. Harbury
536 U.S. 403 (Supreme Court, 2002)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
ITL International, Inc. v. Constenla, S.A.
669 F.3d 493 (Fifth Circuit, 2012)
Bobby D. Lacy v. Sitel Corporation
227 F.3d 290 (Fifth Circuit, 2000)
Pervasive Software, Inc. v. Lexware GMBH & Co. KG
688 F.3d 214 (Fifth Circuit, 2012)
Yatham v. Young
912 So. 2d 467 (Mississippi Supreme Court, 2005)
Century Satellite, Inc. v. Echostar Satellite, L.L.C.
395 F. Supp. 2d 487 (S.D. Texas, 2005)
Dunn v. Yager
58 So. 3d 1171 (Mississippi Supreme Court, 2011)
Bally Gaming, Inc. v. Caldwell
12 F. Supp. 3d 907 (S.D. Mississippi, 2014)
Smith v. Antler Insanity, LLC
58 F. Supp. 3d 716 (S.D. Mississippi, 2014)

Cite This Page — Counsel Stack

Bluebook (online)
Gentex Pharma, LLC v. Glycobiosciences, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/gentex-pharma-llc-v-glycobiosciences-inc-mssd-2020.